Beijing Tide Pharmaceutical Co., Ltd

This study tests a new drug called TDI01 for people with idiopathic pulmonary fibrosis (IPF), a disease that scars the lungs and makes breathing hard. About 508 adults in China will receive either TDI01 or a placebo to see if the drug helps slow lung function decline over 24 to 5…

This study tests a new drug called TCC1727 combined with other medicines (benmelstobart, olaparib, or topotecan) in people with advanced solid tumors, including lung, stomach, endometrial cancer, and melanoma. The goal is to find the safest dose and see if the combination helps s…

This study tests a new painkiller called TRD205 for people recovering from hip replacement surgery. About 200 adults will receive either TRD205, a placebo, or an active comparator (celecoxib) to see how well it controls pain and reduces the need for rescue opioids. The goal is to…

This early-stage study tests whether a new inhaled drug called CPD704 is safe and how the body processes it. It involves 90 healthy Chinese adults aged 18-55. Participants receive single or multiple doses via inhalation and are monitored for side effects and drug levels in the bl…